Author/Creator: Kantecki, Michal - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Kantecki, Michal

1. Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis. Issue 1 (December 2015)

Authors:: Auzinger, Georg; Playford, E.; Graham, Christopher; Knox, Hediyyih; Weinstein, David; Kantecki, Michal; Schlamm, Haran; Charbonneau, Claudie
Journal:: BMC infectious diseases
Issue:: Volume 15:Issue 1(2015)
Page Start:: 1
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. In vitro activity of aztreonam/avibactam against isolates of Enterobacterales collected globally from ATLAS in 2019. (September 2022)

Authors:: Rossolini, Gian Maria; Stone, Gregory; Kantecki, Michal; Arhin, Francis F.
Journal:: Journal of global antimicrobial resistance
Issue:: Volume 30(2022)
Page Start:: 214
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and Efficacy of Anidulafungin for Fungal Infection in Patients With Liver Dysfunction or Multiorgan Failure. (12th November 2016)

Authors:: Verma, Anita; Auzinger, Georg; Kantecki, Michal; Campling, James; Spurden, Dean; Percival, Fran; Heaton, Nigel
Journal:: Open forum infectious diseases
Issue:: Volume 4:Number 1(2017)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials. (March 2022)

Authors:: Dryden, Matthew; Kantecki, Michal; Yan, Jean Li; Stone, Gregory G.; Leister-Tebbe, Heidi; Wilcox, Mark
Journal:: Journal of global antimicrobial resistance
Issue:: Volume 28(2022)
Page Start:: 108
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗